SC to govt: Why can't SMA medicines be as cheap in India as in Pak, China?

The Supreme Court has sought responses from the Centre and pharmaceutical giant Roche on why their SMA treatment drug, Risdiplam, is significantly more expensive in India compared to Pakistan and China. Advocate Anand Grover highlighted the urgent need for price negotiation or generic production to save Indian patients.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/hZ9zOqy